Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by SQZ Biotechnologies Company Asset Sale and Plan of Liquidation and Dissolution Approved by SQZB Shareholders February 29, 2024 From SQZ Biotechnologies Company Via Business Wire Tickers OTC SQZB SQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio Updates November 08, 2023 From SQZ Biotechnologies Company Via Business Wire Tickers OTC SQZB SQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual Meeting November 03, 2023 From SQZ Biotechnologies Company Via Business Wire Tickers OTC SQZB SQZ Biotechnologies Reports Second Quarter 2023 Financial Results and Recent Portfolio Updates August 10, 2023 From SQZ Biotechnologies Company Via Business Wire Tickers OTC SQZB SQZ Biotechnologies Provides Update on Collaboration with Roche July 25, 2023 From SQZ Biotechnologies Company Via Business Wire Tickers OTC SQZB SQZ Biotechnologies to Consolidate Shares with 1-for-10 Reverse Stock Split June 15, 2023 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Reports First Quarter 2023 Financial Results and Recent Portfolio Updates May 10, 2023 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Announces Confirmed Complete Response in HPV16+ Solid Tumor Patient in the Lowest-Dose Cohort of the SQZ-AAC-HPV-101 Clinical Trial March 22, 2023 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Reports Full Year 2022 Financial Results and Recent Portfolio Updates March 22, 2023 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Receives FDA Fast Track Designation for its eAPC Therapeutic Candidate for Treatment of HPV16+ Tumors and Presents Clinical Data for Multiple Programs at the European Society for Medical Oncology Immuno-Oncology Congress December 06, 2022 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Publishes Preclinical Research Demonstrating SQZ® AAC Platform’s Potential as an Effective Red Blood Cell-Derived Immunotherapy October 03, 2022 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Presents Preclinical SQZ® TIL Data Supporting Potential Ability of mRNA-Driven IL-2 and IL-12 Expression to Eliminate Need for Toxic Preconditioning and Systemic IL-2 Administration for Certain T Cell Therapies September 12, 2022 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies to Present at Upcoming Investor Conferences September 07, 2022 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Announces Leadership Transition September 06, 2022 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies and Collaborators Publish Technology Review on SQZ® APCs and Effective CD8 T Cell Activation July 12, 2022 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Presents Celiac Disease Tolerizing Antigen Carrier Preclinical Data at 2022 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting June 21, 2022 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Announces Generation of Dopaminergic Neurons from Human Pluripotent Stem Cells Through Single-Step Delivery of Six Cell-Fate Encoding RNAs June 16, 2022 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Announces Lead Cell Therapy Candidate Induced Radiographic, Symptomatic and Immune Response as Monotherapy in Post-Checkpoint HPV+ Solid Tumor Patient December 09, 2021 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Lead Cell Therapy Candidate Generated Monotherapy Clinical Response Correlated with Substantial CD8 T Cell Tumor Infiltration in HPV+ Solid Tumor at Highest Dose December 02, 2021 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Announces Acceptance by Roche Accelerator in China December 01, 2021 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies to Present at the Stifel 2021 Virtual Healthcare Conference November 15, 2021 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Reports Third Quarter 2021 Financial Results and Recent Portfolio Updates November 10, 2021 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Presents Regenerative Medicine Data Demonstrating Neuron Generation from Human Pluripotent Stem Cells with Single Delivery of mRNA Transcription Factor June 23, 2021 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Initial First-In-Human Data Demonstrates Investigational Cell Therapy is Safe and Can Stimulate Immune Responses in Certain Patients with Advanced or Metastatic HPV16+ Tumors June 04, 2021 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotech to Present at Jefferies Virtual Health Care Conference May 27, 2021 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies to Present First Clinical Data at the American Society of Clinical Oncology Annual Meeting from Ongoing Phase 1 Study in Patients with Advanced or Metastatic HPV+ Tumors May 19, 2021 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ SQZ Biotechnologies Reports First Quarter 2021 Financial Results and Recent Business Highlights May 11, 2021 From SQZ Biotechnologies Company Via Business Wire Tickers SQZ Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.